Mediclove Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 24-10-2024
- Paid Up Capital ₹ 0.10 M
as on 24-10-2024
- Company Age 5 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 11.45%
(FY 2023)
- Profit 13.26%
(FY 2023)
- Ebitda 36.44%
(FY 2023)
- Net Worth 66.10%
(FY 2023)
- Total Assets 56.89%
(FY 2023)
About Mediclove Biotech
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Manvinder Rana and Ranvinder Rana serve as directors at the Company.
- CIN/LLPIN
U24239HR2019PTC081221
- Company No.
081221
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Jul 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Panchkula, Haryana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Mediclove Biotech Private Limited offer?
Mediclove Biotech Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Dietary Supplements, Common Disease Medicines, Pharmaceutical Capsules, Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Digestive System Drugs & Medicines, Antacid Drugs, Hand Sanitizers & Personal Hygiene, Hand Sanitizer & Disinfectant.
Who are the key members and board of directors at Mediclove Biotech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manvinder Rana  | Director | 01-Jul-2019 | Current |
| Ranvinder Rana | Director | 06-Jul-2022 | Current |
Financial Performance of Mediclove Biotech.
Mediclove Biotech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 11.45% increase. The company also saw a substantial improvement in profitability, with a 13.26% increase in profit. The company's net worth Soared by an impressive increase of 66.1%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mediclove Biotech?
Unlock access to Mediclove Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Kepsulin Pharma Private LimitedActive 1 month 3 daysManvinder Rana and Ranvinder Rana are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Mediclove Biotech?
Unlock and access historical data on people associated with Mediclove Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mediclove Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mediclove Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
